Latest
Hoover Institution | Stanford University
Healthcare Policy
Featured
Benchmark Reform in Medicare Advantage
This Week in Health Care Policy
A weekly roundup of health policy news.
October 31-November 6, 2026 Read this week's roundup →Previous weeks
Quote
Radio
Other Featured Works
- How The No Surprises Act worsened the problem of surprise bills
- Comment on Medicare Reimbursement for 340B Drugs
- State Directed Payments
- Six takeaways from the recent Obamacare announcements
- America is the world's jet engine of prosperity
- Government shouldn't run AI
- How AI is already improving lives
- Wall Street and Main Street Aren’t Separable
Other Work
- New legislation seeks to shuffle the deck chairs on the sinking No Surprises Act
- Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
- FDA deserves credit for approving pancreatic cancer drug
- OBBBA Puts SNAP Spending Back on Its Pre-Pandemic Path
- What Trump’s vaccine executive order actually does
- FDA Approves First mRNA Flu Vaccine
- FDA succeeds in approving new flu vaccine: CEI comment
- Trump administration decision highlights disastrous Part D redesign
Current Events in Health Care Policy
- Feds deny recertification to 2 No Surprises arbitrators
- 6 thinks to know about Medicare's 2nd round of negotiated drug prices
- Study says physicians prefer AI discharge summaries in 95% of cases
- AbbVie wins drug price control lawsuit against HHS
- Model projects lower Medicare Advantage bonuses from removing star-rating measures
- Supplemental Rebates From Drug Makers To State Medicaid Programs Grew Fivefold From 2017 To 2024
- Senator's draft bill would create healthcare AI payment pathway
- Labor finalizes PBM compensation disclosures and audit rights for large employer plans